Zhejiang Shengda Bio-Pharm Co., Ltd. (SHA:603079)

Market Cap	2.41B -9.4%
Revenue (ttm)	830.53M -1.8%
Net Income	53.62M +13.3%
EPS	0.29 +3.6%
Shares Out	187.44M
PE Ratio	43.86
Forward PE	n/a
Dividend	0.10 (0.77%)
Ex-Dividend Date	n/a

Volume	1,683,600
Open	12.70
Previous Close	12.86
Day's Range	12.56 - 12.95
52-Week Range	12.57 - 22.00
Beta	0.31
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHA:603079

Zhejiang Shengda Bio-Pharm Co., Ltd. develops, produces, and sells food and feed additives for pharmaceutical, nutritional, food, and animal feed industry. It offers vitamins, such as biotin and folic acid; biological preservatives, including nisin, polylysine, and natamycin; and intermediate APIs. The company was incorporated in 1999 and is headquartered in Tiantai, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 1,035
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603079

Financial Performance

In 2025, SHA:603079's revenue was 844.54 million, an increase of 2.07% compared to the previous year's 827.40 million. Earnings were 62.16 million, an increase of 111.24%.